Rare diseases
Investigational molecules
Locations
Back to France3 418 clinical trials in Clichy, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effects of Mitapivat for Patients with Transfusion-Dependent Alpha or Beta Thalassemia
FranceStudy on Emicizumab for Patients with Mild or Moderate Hemophilia A Without FVIII Inhibitors
FranceStudy on Itacitinib for Adults with Diffuse Systemic Sclerosis
FranceStudy of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate
FranceStudy Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension
FranceStudy Comparing XL092 and Atezolizumab with Regorafenib for Patients with Metastatic Colorectal Cancer
FranceStudy of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer
FranceStudy of Atezolizumab and Tiragolumab for Patients with Recurrent or Metastatic PD-L1 Positive Head and Neck Squamous Cell Carcinoma
FranceStudy of Relacorilant and Nab-Paclitaxel for Patients with Advanced, Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
FranceStudy on L19IL2 and L19TNF Treatment Before Surgery for Patients with Advanced Melanoma
FranceStudy on the Effectiveness and Safety of Golimumab for Children with Moderate to Severe Ulcerative Colitis
FranceFranceThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on inflammatory bowel diseases and advanced treatment methods, including studies on Crohn's disease and ulcerative colitis using fecal microbiota transplantation as therapeutic approaches.
Research aims to improve patient outcomes through novel therapeutic interventions and treatment strategies.
Comprehensive studies on liver diseases and biliary tract conditions, investigating new treatments for cirrhosis, portal hypertension, and various forms of liver cancer.
Advanced therapeutic approaches combining immunotherapy and targeted treatments.
Groundbreaking research on pancreatic cancer and metabolic conditions, evaluating novel drug combinations and treatment protocols.
Focus on improving survival rates and treatment efficacy in advanced-stage diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
